Novan to Provide Corporate Update at its 2023 Annual Meeting of Stockholders
05 juin 2023 09h00 HE
|
Novan, Inc.
DURHAM, N.C., June 05, 2023 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that it will host a live audio webcast of the Company’s 2023 Annual Meeting of...
Novan to Report Full Year 2022 Financial Results on March 30, 2023
23 mars 2023 09h00 HE
|
Novan, Inc.
DURHAM, N.C., March 23, 2023 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that it will report its full year 2022 financial results on Thursday,...
Healthy Extracts Introduces New Video Series Hosted by Fitness & Nutrition Expert, Whitney Johns, and America’s Healthy Heart Doc, Joel Kahn
03 nov. 2022 08h31 HE
|
Healthy Extracts Inc.
LAS VEGAS, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Healthy Extracts Inc. (OTCQB: HYEX), a leading innovator of clinically proven plant-based products for heart and brain health, has launched a new...
Healthy Extracts’ WHITNEY JOHNS ACTIVE™ Clinically Proven to Enhance Physical Performance by Increasing Nitric Oxide by 73% and Oxygen Consumption by 24%
22 juin 2022 08h31 HE
|
Healthy Extracts Inc.
LAS VEGAS, June 22, 2022 (GLOBE NEWSWIRE) -- Healthy Extracts Inc. (OTCQB: HYEX), a leading innovator of clinically proven plant-based products for heart and brain health, reported that a key...
Novan Announces Late-Breaking Abstract Accepted for Presentation at American Academy of Dermatology’s (AAD) 2022 Annual Meeting
24 mars 2022 09h00 HE
|
Novan, Inc.
DURHAM, N.C., March 24, 2022 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that data from its pivotal Phase 3 study of berdazimer gel 10.3% (SB206) for...
Novan Acquires EPI Health, a Specialty Dermatology Company
11 mars 2022 06h35 HE
|
Novan, Inc.
– EPI Health promotes four prescription products posting 2021 operating revenue of $17.6 million – – Acquisition forward integrates Novan with complementary commercial infrastructure to drive...
Novan Reports Full Year 2021 Financial Results and Provides Corporate Update
22 févr. 2022 07h00 HE
|
Novan, Inc.
– First New Drug Application (NDA) submission targeted in Q4 2022 for lead program SB206 (berdazimer gel 10.3%) for molluscum contagiosum – – Ongoing advancement of priority development pipeline...
Novan to Report Full Year 2021 Financial Results on February 22, 2022
15 févr. 2022 09h00 HE
|
Novan, Inc.
DURHAM, N.C., Feb. 15, 2022 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that it will report its full year 2021 financial results on Tuesday, February...
Leader in Molecular Medicine Wants Nitric Oxide in the Hands of Every Person
17 janv. 2022 09h00 HE
|
Berkeley Life
CHICAGO, Jan. 17, 2022 (GLOBE NEWSWIRE) -- Today, Dr. Nathan S. Bryan, world-renowned molecular medicine and nitric oxide expert and founder of Pneuma Nitric Oxide, LLC and Bryan Nitriceuticals,...
Novan Announces Presentation of Two Posters at the 2022 Winter Clinical Dermatology Conference
14 janv. 2022 09h05 HE
|
Novan, Inc.
DURHAM, N.C., Jan. 14, 2022 (GLOBE NEWSWIRE) -- Novan, Inc. (“the Company” or “Novan”) (Nasdaq: NOVN), today announced that data from the Company’s completed Phase 2 and Phase 3 clinical studies of...